Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I

Abstract

Background: Testing for the antiphospholipid syndrome (APS) using anticardiolipin antibodies (aCL) has been problematic. Titers may fluctuate or even become negative. Anti-beta 2 glycoprotein I assays (ab2-GPI) may be more reliable for diagnosis.

Methods: In a prospective, blinded study over a nine-month period we retested all patients seen for routine follow-up visits in our clinic who had previously been evaluated for aCL-associated illnesses. Patients were stratified into two groups: group A—patients previously positive (/) for aCL; group B—patients previously negative (7) for aCL. Both groups were further classified according to disease severity. Patients were retested for both aCL and ab2-GPI (isotypes G, M, A for each) using uniform testing standards.

Results: 118 patients with previously positive aCL (group A) were retested. Repeat aCL were positive in 52=118 (44%), ab2-GPI positive in 69=118 (58%) and 82=118 (69.5%) were positive for one or both assays. In patients with serious organ damage (92% with documented APS), 48.6% were aCL positive, 64% positive for ab2-GPI, and 75.7% were positive for one or both assays. When only one assay was positive, ab2-GPI was most frequent (P = 0.0096). Overall, IgA ab2-GPI was the most frequent isotype found (60.9%).

On retesting of 73 aCL-negative patients (group B), 9=73 (12%) were aCL positive, 27=73 (36%) were ab2-GPI positive, with 24=73 (32.9%) having isolated ab2-GPI. Of those positive for ab2 GPI, IgA ab2-GPI was present in 74.1%. Many of these patients had documented APS.

Conclusion: Based on our data, ab2-GPI assays are superior to aCL assays for diagnosis of APS. The combined use of both assays enhance positive testing results in up to 75% of patients with APS at any stage of illness. ACL negative patients suspected of having APS should be retested for both ab2-GPI and aCL. IgA ab2-GPI appears to be the most important isotype detected.

Keywords

antiphospholipid antibodies anti-beta 2-glycoprotein I antiphospholipid syndrome

Get full access to this article

View all access options for this article.

References

Petri M. Diagnosis of antiphospholipid antibodies . Rheum Dis Clin North Am 1994; 20(2): 443–469 .

Lockshin MD . Antiphospholipid antibody syndrome . Rheum Dis Clin North Am 1994; 20(1): 45–59 .

Bick RL , Baker WF Jr. The antiphospholipid and thrombosis syndrome . Med Clin North Am 1994; 78(3): 667–684 .

Harris N : Antiphospholipid syndrome. In: Klippel J , Dieppe P (ed). Rheumatology Mosby: New York , 1994; Sections 6P32.1–6P32.6.

Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome . Med Clin North Am 1997; 81(1): 151–177 .

Levy RA . Clinical manifestations of the aPL syndrome . Lupus 1996; 5(5): 393–397 .

Piette JC . 1996

diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: A ‘mission impossible’?

Lupus 1996; 5(5): 354–363 .

Hughes GRV . The antiphospholipid syndrome . Lupus 1996; 5(5): 345–346 .

Gharavi AE , Wilson WA . The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome . Lupus 1996; 5(5): 343–344 .

10.

Triplet DA . Protean clinical presentation of antiphospholipid-protein antibodies (APA) . Thromb Haemost 1995; 74(1): 329–337 .

11.

Cines DB , McCrae KR . The antiphospholipid-protein syndrome . J Clin Immunol 1995; 15 (6)(Suppl): 86S–100S .

12.

Alarcon-Sergovia D , Cabral AR . The concept and classification of antiphospholipid/cofactor syndromes . Lupus 1996; 5(5): 364–367 .

13.

Kandiah DA , Sheng YH , Krilis SA . b2 glycoprotein I: Target antigen for autoantibodies in the antiphospholipid syndrome . Lupus 1996; 5(5): 381–385 .

14.

Roubey RAS . Antigenic specificities of antiphospholipid autoantibodies: Implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome . Lupus 1996; 5(5): 425–430 .

15.

Lockshin MD . Pathogenesis of the antiphospholipid syndrome . Lupus 1996; 5(5): 404–408 .

16.

Tincani A , Spatola L , Cattaneo R et al. Antiphospholipid ELISA: the state of the art . Lupus 1996; 5(5): 477–479 .

17.

Reber G , Cornby E , Degenne D et al. Multicenter evaluation of nine kits for the quantitation of anticardiolipid antibodies . Thromb Haemost 1995; 52: 444–452 .

18.

Ferro D , Valensini G , Basili S et al. Transient antiphospholipid antibodies (APLA) positivity in patients with primary antiphospholipid syndrome . Lupus 1996; 5(5): 551-551 .

19.

Harris EN , Gharavi AE , Patel SP , Hughes GRV . Evaluation of the anticardiolipin antibody test. Report of an international workshop held April 4, 1986 . Clin Exp Immunol 1987; 68: 215–222 .

20.

Wilson WA , Gharavi AE , Koike T et al. International Consensus Statement on Preliminary Classification Criteria for Definite Antiphospholipid Syndrome . Arthritis Rheum 1999; 42: 1309–1311 .

21.

Cabral AR , Amigo MC , Cabiedes J , Alarcon-Sergovia D . The antiphospholipid/cofactor syndromes: A primary variant with anti bodies to b2 GPI but no antibodies detectable in standard assays . Am J Med 1996; 101: 472–481 .

22.

Schousboe I. b2–glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway . Blood 1985; 66: 1086–1091 .

23.

Nimpf J , Bevers EM , Bomans PHH . Prothrombinase activity of human platelets is inhibited by b-glycoprotein I . Biochem Biophys Acta 1986; 884: 142–149 .

24.

Schousboe I. Binding of b2-glycoprotein I to platelets: effect of adenylate cyclase activity . Thromb Res 1980; 19: 225–237 .

25.

Matsuda J , Gotch M , Gohchi K et al. Resistance to activated protein C activity of an anti-b2-glycoprotein antibody in the presence of b2 glycoprotein I . Br J Haematol 1995; 90: 204–206 .

26.

Shi W , Chong BH , Hogg PJ , Chesterman CN . Anticardiolipin antibodies block the inhibition of b2-glycoprotein I of the factor-Xa generating activity of platelets . Thromb Haemost 1993; 70: 342–345 .

27.

Arvieux J , Pouzol P , Roussel B et al. Lupus-like anticoagulant properties of murine monoclonal antibodies to b2-glycoprotein I . Br J Haematol 1993; 81: 568–573 .

28.

Arvieux J , Roussel B , Pouzol P , Colomb MG . Platelet activating properties of murine monoclonal antibodies to b2-glycoprotein I . Thromb Haemostas 1993; 70: 336–341 .

29.

Hughes GRV . Hughes' syndrome: The antiphospholipid syndrome. A historical view . Lupus 1998; 7(2): S1–S4 .

30.

Sheng Y , Kandiah A , Krilis SA . b2-Glycoprotein 1: target antigen for ‘antiphospholipid’ antibodies. Immunological and molecular aspects . Lupus 1998; 7(2): S5–S9 .

31.

Kamboh MI , Mehdi H . Genetics of apolipoprotein H (b2-glyco protein 1) and anionic phospholipid binding . Lupus 1998; 7(2): S10–S13 .

32.

Koike T , Ichikawa K , Kasahara H et al. Epitopes on b2-GPI recognized by anticardiolipin antibodies . Lupus 1998; 7(2): S14–S17 .

33.

Meroni PL , Del Papa N , Rasch E et al. b2-Glycoprotein 1 as a ‘cofactor’ for anti-phospholipid reactivity with endothelial cells . Lupus 1998; 7(2): S44–S47 .

34.

Gharavi AE , Pierangeli SS . Origin of antiphospholipid antibodies: induction of aPL by viral peptides . Lupus 1998; 7(2): S52–S54 .

35.

Tsutsumi A , Ichikawa K , Matsuura E , Koike T . Anti-b2-glycoprotein 1 antibodies . Lupus 1998; 7(2): S103–S106 .

36.

Tincani A , Spatola L , Cinquini M et al. Anti-b2-glycoprotein 1 antibodies: clinical significance . Lupus 1998; 7(2): S107–S109 .

37.

Triplett DA . Many faces of lupus anticoagulants . Lupus 1998; 7(2): S18–S22 .

38.

Rauch J. Lupus anticoagulant antibodies: Recognition of phospholipidbinding protein complexes . Lupus 1998; 7(2): S29–S31 .

39.

de Groot PG , Horbach DA , Simmelink MJA et al. Antiprothrombin antibodies and their relation with thrombosis and lupus anticoagulant . Lupus 1998; 7(2): S32–S36 .

40.

Galli M , Barbui T . Prothrombin as cofactor for antiphospholipids . Lupus 1998; 7(2): S37–S40 .

41.

Wilson WA , Faghiri Z , Taheri F , Gharavi AE . Significance of IgA antiphospholipid antibodies . Lupus 1998; 7(2): S110–S113 .

42.

Harris EN , Pierangeli SS , Gharavi AE . Diagnosis of the antiphospholipid syndrome: A proposal for use of laboratory tests . Lupus 1998; 7(2): S144–S148 .